KUNKEL LORI ANNE sold 16.2% of their position (10K shares) of ENLIVEN THERAPEUTICS, INC. on the open market
Open‑market sale worth $345.4K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/9/2026ACC: 0001536368-26-000004
Director
Since Feb 2026
-10K
Net shares
Net seller
$345.4K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
10K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−7.78K
Price / share
$34.28
Trade value
$266.66K
% of position
12.6%
6/5/2026
61.88K→54.10K
Common Stock
Direct
Shares
−1.87K
Price / share
$35.36
Trade value
$66.01K
% of position
3.5%
6/5/2026
54.10K→52.24K
Common Stock
Direct
Shares
−354.00
Price / share
$35.82
Trade value
$12.68K
% of position
0.7%
6/5/2026
52.24K→51.88K
Total
Net shares
−10K
Net value
-$345.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/5/2026 | S · Sale | −7.78K | $34.28 | $266.66K | 12.6% | 61.88K | 54.10K |
| Common Stock Direct | 6/5/2026 | S · Sale | −1.87K | $35.36 | $66.01K | 3.5% | 54.10K | 52.24K |
| Common Stock Direct | 6/5/2026 | S · Sale | −354.00 | $35.82 | $12.68K | 0.7% | 52.24K | 51.88K |
| Total | −10K | -$345.35K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned0.00
Total
0.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 0.00 | Indirect |
| Total | 0.00 |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported